The umbilical cord is rich with powerful stem cells - hematopoietic stem cells (HSCs) to be precise. Umbilical cord blood stem cells are FDA-approved to treat cancers, blood disorders, immune disorders, and metabolic disorders, such as multiple sclerosis, leukemia, and sickle cell anemia.

The tissue of a baby's umbilical cord is filled with mesenchymal stem cells (MSCs). Umbilical cord tissue stem cells are the subject of clinical research looking at treatments for lung disease, Alzheimer's, Autism, heart disease, hair loss, and more. In the case of personal injury or physical ailments, these can potentially be extremely helpful.

The placenta is rich with mesenchymal stem cells. These stem cells have valuable growth elements, which are potentially effective when it comes to anti-aging, limiting neural degeneration, and more.

HSC treatments are standard-of-care for multiple sclerosis treatments, and it has additionally been successfully used to treat cancers like leukemia and metabolic, immune, and blood disorders, such as Krabbe disease and sickle cell disease. Over 1300 clinical trials are currently being conducted to examine how it can treat neurological conditions as well - including cerebral palsy and Autism.

‍